Gonal-f 900 iu1.5 ml (66 mcg1.5 ml) Solution for Injection in a pre-filled pen Singapore - English - HSA (Health Sciences Authority)

gonal-f 900 iu1.5 ml (66 mcg1.5 ml) solution for injection in a pre-filled pen

merck pte. ltd. - follitropin alfa - injection, solution - 66.69 mcg - follitropin alfa 66.69 mcg

Bifiteral 66.7 g/100 ml syrup Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bifiteral 66.7 g/100 ml syrup

viatris healthcare sa-nv - lactulose 66,7 g/100 ml - syrup - 66,7 g/100 ml - lactulose 666.66 mg/ml - lactulose

Medijel Gel 0.66%,0.05%W/W 0.66%w/w, 0.05%w/w Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

medijel gel 0.66%,0.05%w/w 0.66%w/w, 0.05%w/w

مستودع ادوية فزع - مستودع ادوية فزع - lidocaine hydrochloride 0.66 %w/w, aminoacridine hydrochloride 0.05 %w/w - 0.66%w/w, 0.05%w/w

Rectolyn Suppositories 66.6 mg, 3.3 mg, 66.6 mg, 66.6 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

rectolyn suppositories 66.6 mg, 3.3 mg, 66.6 mg, 66.6 mg

شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - paracetamol 66.6 mg, oxomemazine 3.3 mg, guaifenesin 66.6 mg, sodium benzoate 66.6 mg - 66.6 mg, 3.3 mg, 66.6 mg, 66.6 mg

Actilax New Zealand - English - Medsafe (Medicines Safety Authority)

actilax

viatris limited - lactulose 66%{relative} - syrup - 66% w/v - active: lactulose 66%{relative} - treatment of acute, and prevention and treatment of portal-systemic encephalopathy (pse), including the stages of hepatic precoma and coma.

Duphalac New Zealand - English - Medsafe (Medicines Safety Authority)

duphalac

viatris limited - lactulose 66.7%{relative};   - syrup - 66.7% w/v - active: lactulose 66.7%{relative}  

Lactulose New Zealand - English - Medsafe (Medicines Safety Authority)

lactulose

viatris limited - lactulose 66%{relative};   - syrup - 66% w/v - active: lactulose 66%{relative}  

Medijel oromucosal gelLidocaine hydrochloride 0.66% w/wAminoacridine hydrochloride 0.05% w/w Ireland - English - HPRA (Health Products Regulatory Authority)

medijel oromucosal gellidocaine hydrochloride 0.66% w/waminoacridine hydrochloride 0.05% w/w

d.d.d. limited - aminacrine hydrochloride; lignocaine hydrochloride - oromucosal gel - 0.66 %w/w +0.05 percent weight/weight - anesthetics for topical use; lidocaine; acridine derivatives

LACTUS SYRUP 66% wv Singapore - English - HSA (Health Sciences Authority)

lactus syrup 66% wv

icm pharma pte. ltd. - lactulose - syrup - 66% w/v - lactulose 66% w/v

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE solution United States - English - NLM (National Library of Medicine)

ipratropium bromide and albuterol sulfate solution

actavis pharma, inc. - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide anhydrous 0.5 mg in 3 ml - ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives. ipratropium bromide and albuterol sulfate inhalation solution 0.5 mg/3 mg per 3 ml  read this patient information completely every time your prescription is filled as information may have changed. keep these instructions with your medication as you may want to read them again. ipratropium bromide and albuterol sulfate inhalation solution should only be used under the direction of a physician. your physician and pharmacist have more information about ipratropium bromide and albuterol sulfate inhalation solution and the condition for which it has been prescribed. contact them if you have additional questions. storing your medicine store ipratrop